Life Insurance Over 50 No Medical - Compare UK Policies & Get Free Quotes

The mechanics behind no-medical over-50 cover

What "no medical" actually means on a UK over-50 plan is specific. The insurer does not ask about pre-existing conditions, ongoing treatment, medication, family history of serious illness, BMI, alcohol intake, or most of the usual underwriting questions. It does ask about smoker status (which affects the premium band) and age (which is the single biggest pricing input). Everything else is pooled across the age band.

Because there is no medical underwriting, the claim process on an over-50 plan is simpler than on fully-underwritten cover. The beneficiary provides the death certificate, the claim form, and confirmation of identity — the insurer confirms the waiting period has passed and pays the fixed sum assured. Claims statistics on UK over-50 plans sit in line with the wider life insurance market (in the high-90s as a claims-paid percentage), driven mostly by beneficiaries claiming outside the terms rather than policy disputes.

What over-50 life insurance actually is as a product

UK over-50 plans are engineered around a single trade: certainty of acceptance for everyone inside the age band in exchange for a small, capped sum assured and a short period where non-accidental death is not fully covered. The contract is designed to be priceable without individual underwriting, which is why the premium is the same for every applicant of the same age at the same provider.

Over-50 plans are regulated in the UK as long-term insurance contracts, with FSCS protection at 100% of the claim amount. The core product terms are narrow enough that the FCA's protection rules apply uniformly across providers; the differences between providers are at the margin — waiting-period length, cancellation-refund terms, promotional inducements, inflation-indexing features — rather than in the fundamental mechanics.

Where the product stops being good value on paper

Providers protect against the break-even problem in two ways. Some plans cap total premiums at a set age (typically 90 or 95): cover continues but no further premiums are charged, which preserves the product's value for long-lived policyholders. Others apply inflation indexation to the sum assured, raising it annually in line with RPI — so the break-even arithmetic is in inflation-adjusted terms rather than nominal ones.

The comparison that really matters for the break-even arithmetic is between over-50 plans and the two alternatives most applicants could consider: a fully-underwritten whole-of-life policy (better cover-per-pound if underwriting accepts), and a simple savings account (no guarantee but full flexibility). The over-50 plan wins where both of those alternatives fail — difficult medical history plus the need for certainty of payout.

How providers price this product

Small product variations move the premium but not dramatically. A shorter waiting period (12 months vs 24 months) typically carries a small premium uplift. Inflation-indexed sum assured raises the premium by 3–5% initially and by a compound increase each year. Cancellation-refund terms and promotional inducements are priced into the headline rate rather than shown as separate line items.

One cost factor worth understanding: some UK over-50 providers operate as "distribution brands" where the underlying underwriter is a different legal entity. The premium difference between two distribution brands selling the same underlying policy is sometimes 20% or more, reflecting acquisition costs and marketing spend rather than product differences. The FCA-regulated underwriter on the schedule is what matters for claims and FSCS protection; the brand name on the policy is mostly a marketing choice.

Numbers from a typical quote

A 67-year-old with a cancer diagnosis five years earlier, currently in full remission but declined by three fully-underwritten insurers, applies for a £10,000 guaranteed-acceptance over-50 plan and is issued cover the same day at £46/month. The policy carries a 12-month waiting period; the applicant dies from an unrelated cardiac event 14 months later, and the full £10,000 pays out cleanly to the named beneficiary without disclosure review. This is exactly the case the product is designed for.